Delivery Order SPE2DR25D3201-SPE2DR26FT5SQ
Award Date 1/28/26
Potential Completion Date 2/19/26
Potential Value $90K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a $8,116.87 delivery order award from the Defense Logistics Agency on September 10, 2025, for IMBRUVICA 140 mg capsules (90-count supply). The contract operates under firm fixed-price terms with an ultimate completion date of October 1, 2025, and was awarded competitively with no set-aside designation. This delivery order is a child contract issued against AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $21,382.08 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of IMBRUVICA (ibrutinib) 140 mg capsules in quantities of 90, with delivery scheduled to be completed by February 5, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,405.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (120-count units) on November 28, 2025. This is a firm fixed price, non-set-aside contract with a completion date of December 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Imbruvica 140 mg capsules (120-count units) with a ceiling value of $10,822.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by November 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on April 22, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by May 13, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $15,967.36 delivery order to AmerisourceBergen Drug Corp for 28 Imbruvica 70 mg capsules on November 17, 2025, with completion targeted for December 9, 2025. This firm fixed-price delivery order utilizes no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,215.76 to AmerisourceBergen Drug Corp for 90 units of Imbruvica 140mg, a prescription medication used primarily in the treatment of certain blood cancers and lymphoid malignancies. This competitively awarded, firm fixed-price delivery order was issued on December 18, 2025, with an ultimate completion date of January 12, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on August 18, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $8,116.87 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Imbruvica 140 mg capsules (90-count units). This non-set-aside, competitively awarded delivery order is scheduled for completion by October 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,845.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 140 mg Imbruvica capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide....